COGT
COGT
NASDAQ · Biotechnology

Cogent Biosciences Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$34.74
-0.05 (-0.14%)
As of May 9, 1:17 AM ET ·
Analyst Consensus
Strong Buy
19
Analysts
High
Coverage
Buy 16 84%
Hold 3 16%
Sell 0 0%
Price Target
Analyst Price Target +141.7% upside
Low Target $51.90
Average Target $83.97
High Target $108.57
Current Price $34.74
Current
$34.74
Target
$83.97
$51.90 $83.97 avg $108.57
Scenario Analysis
Bear Case
$51.90
49.4%
Low target
Base Case
$83.97
+141.7%
Avg target
Bull Case
$108.57
+212.5%
High target
Risk/Reward
4.3x
Highly favorable
Price in Context
52-Week High
$43.73
-20.6% from high
52-Week Low
$4.55
+663.5% from low
50-Day SMA
$37.85
-8.2% vs SMA
200-Day SMA
$20.09
+72.9% vs SMA
RSI (14)
53.0
Neutral
Target vs 52W High
$83.97
+92.0% vs high
Next Earnings Report
May 12, 2026
2d
until earnings
EPS Est: $-0.55
Earnings in 2 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Buy 39 72% $257.58 +27.8%
AMGN
Amgen Inc
 Hold 43 49% $190.87 -42.5%
GILD
Gilead Sciences Inc
 Strong Buy 39 79% $362.68 +176.2%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 +2.0%
REGN
Regeneron Pharmaceuticals
 Strong Buy 38 79% $76.80 -89.3%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -65.3%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -19.5%
INSM
Insmed Inc
 Strong Buy 26 96% $143.40 +41.5%